Skip to NavigationSkip to content

Pharmafile - Research and Development News

Novartis has declared new findings for Entresto, showing that the drug proved itself superior to enalapril-a in patients with heart failure with...
AstraZeneca has revealed new data for its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin) at the American Heart...
Check out this week’s top ten most popular stories on Pharmafile.com!
A Phase 2 study sponsored by The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health, has...
Antibiotic resistant superbugs will kill more than 90,000 British people over the next thirty years if action is not taken to halt rise of...
The US Department of Defence has awarded a coalition of researchers $2 million to fund a three year project intended to explore new therapeutic...
Former Celgene CEO Bob Hugin has failed in his bid to win over the people of New Jersey, after voters last night elected Democratic candidate Bob...
The FDA has seen fit to approve Bristol-Myers Squibb’s Empliciti (elotuzumab) intravenous injection in combination with pomalidomide and...
Eli Lilly has revealed new data on Trulicity (dulaglutide), showing that glucagon-like peptide-1 (GLP-1) receptor agonist achieved its primary...
More than 60 different pharmaceutical compounds were detected in aquatic invertebrate larvae and riparian predators in six streams near Melbourne,...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches